• Multisystem granulomatous disease of unknown origin
  • Commonly affects adults aged 20-40
  • Afro-Caribbeans more frequently affected

 

Clinical features

  • Often asymptomatic – discovered with routine CXR
  • Acute sarcoidosis can present with erythema nodosum and polyarthralgia

 

Pulmonary disease

  • Bilateral hilar lymphadenopathy
  • Pulmonary infiltrates
  • Fibrosis
  • Symptoms – dry cough, progressive dyspnoea, decreased exercise tolerance and chest pain

 

Non-pulmonary manifestations

  • Lymphadenopathy
  • Hepatomegaly
  • Splenomegaly
  • Uveitis, conjunctivitis, keratoconjunctivitis, sicca, glaucoma
  • Terminal phalangeal bone cysts
  • Enlargement of parotid and lacrimal glands
  • Bell’s palsy, meningitis, neuropathy, SOL
  • Erythema nodosum, subcutaneous nodules
  • Cardiomyopathy
  • Arrhythmias
  • Hypercalcaemia, hypercalciuria, renal stones
  • Pituitary dysfunction

 

Tests

Bloods – raised ESR, lymphopenia, raised LFTs, raised serum ACE, raised Ca+, raised Ig

  • 24hr urine – raised Ca+
  • Tuberculin skin test –generally negative
  • CXR
    • Stage 0 – normal
    • Stage 1 – BHL
    • Stage 2 – BHL plus peripheral pulmonary infiltrates
    • Stage 3 – peripheral pulmonary infiltrates alone
    • Stage 4 – progressive pulmonary fibrosis, honeycombing, pleural involvement
  • ECG – may show arrhythmia or BBB
  • Lung function – may be normal or may show restrictive defect
  • Tissue biopsy – non-caseating granuloma
  • Bronchoalveolar lavage – shows increased lymphocytes in active disease and increased neutrophils with pulmonary fibrosis

 

 

Management

  • Patients with BHL don’t require treatment as the majority will resolve on their own
  • Acute sarcoidosis – bed rest, NSAIDs

 

Indications for corticosteroid treatment;

  • Parenchymal lung disease
  • Uveitis
  • Hypercalcaemia
  • Neurological or cardiac involvement
  • Prednisolone 40mg/24hr for 4-6 weeks and then reduced dose for 1yr according to clinical status
  • In severe disease IV methylprednisolone or immunosuppressants may be required

 

Prognosis

  • 60% show spontaneous resolution after 2 years
  • 20% respond to standard steroids
  • 20% don’t improve despite therapy

 

Causes of BHL

  • Sarcoidosis
  • Infection
    • TB
    • Mycoplasma
  • Malignancy
    • Lymphoma
    • Carcinoma
    • Mediastinal tumours
  • Organic dust disease
    • Silicosis
    • Berylliosis
  • Extrinsic allergic alveolitis

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>